Madam Speaker, it only costs $27 in the United Kingdom and Sweden, and $15 in New Zealand, so we can see very clearly that this would save Canadians money. If colleagues just read the Hoskins report, they would see that the pharmacare strategy would save small businesses and employers money as well. This is a benefit to Canadians.
In the House of Commons on March 12th, 2020. See this statement in context.